Dendritic cell vaccine (SBI Biotech)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDendritic cell vaccine (SBI Biotech)

Drug Alias Name树突状细胞疫苗 - SBI BiotechImmunocell Therapy Project

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulantsDendritic cells stimulants

TargetsNot applicable

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSbi Biotech Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSbi Biotech Co Ltd

Active IndicationsN/A

Inactive IndicationsMelanoma

Other Information

ATC CodeN/A